Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Oasmia Pharmaceutical AB (publ) (OASM)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Oasmia Pharmaceutical AB is a pharmaceutical company. It develops a new generation of drugs within human and veterinary oncology. It has two approved products: Paclical and Paccal Vet-CA1.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.524 - 1.531 1.531 - 1.537
Low: 1.459 - 1.469 1.469 - 1.478
Close: 1.486 - 1.501 1.501 - 1.514

Technical analysis

as of: 2019-09-27 4:28:34 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.15     One year: 2.44
Support: Support1: 1.44    Support2: 1.20
Resistance: Resistance1: 1.84    Resistance2: 2.09
Pivot: 1.59
Moving Average: MA(5): 1.53     MA(20): 1.65
MA(100): 1.78     MA(250):
MACD: MACD(12,26): -0.07     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 18.04     %D(3): 21.17
RSI: RSI(14): 44.44
52-week: High: 5.70  Low: 0.94  Change(%): -32.0
Average Vol(K): 3-Month: 24464  10-Days: 1038

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OASM has closed above bottom band by 21.8%. Bollinger Bands are 47.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to OASM's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 30 Dec 2019
Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019 - GlobeNewswire

Mon, 11 Nov 2019
Oasmia resolves on a rights issue of approximately SEK 399 million - GlobeNewswire

Mon, 14 Oct 2019
Notice of extraordinary general meeting in Oasmia Pharmaceutical AB - GlobeNewswire

Fri, 28 Jun 2019
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019 - GlobeNewswire

Fri, 06 Dec 2019
Oasmia's rights issue has been oversubscribed Stockholm Stock Exchange:OASM - GlobeNewswire

Mon, 09 Dec 2019
Final result of the rights issue in Oasmia - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA
Industry:  NA
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2017-07-24
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.